The European Commission announced on Thursday that it has imposed fines totaling 13.4 million euros (approximately $14.1 million) on five pharmaceutical companies, marking the conclusion of their antitrust investigation.
The Commission levied penalties on Alkaloids of Australia, Alkaloids Corporation, Boehringer, Linnea, and Transo-Pharm for their involvement in a cartel that aimed to manipulate the minimum price of a crucial ingredient used in the production of abdominal antispasmodic drugs.
The substance at the center of this cartel was identified as N-Butylbromide Scopolamine/Hyoscine, referred to as ‘SNBB.’ SNBB serves as a vital component in the manufacturing of the abdominal antispasmodic drug Buscopan and its generic variations.
The Commission’s extensive investigation brought to light that these six companies had cooperated in fixing the minimum sales price of SNBB for their customers, which primarily included distributors and generic drug manufacturers. Additionally, they had engaged in the allocation of quotas and exchanged commercially sensitive information.
Read more: Pharma Giant Charged With Price-Fixing In Generics Probe
The fines imposed on these pharmaceutical companies were determined in line with the Commission’s 2006 Guidelines on fines. These guidelines provide a structured framework for calculating penalties in cases of antitrust violations.
The Commission considered various factors when setting the fines, including the value of SNBB sales associated with the violation, the complexity and multifaceted nature of the antitrust infringement, the geographic extent of the cartel’s operations, and the duration of their illicit activities.
Source: Reuters
Featured News
Uruguayan Antitrust Scrutiny Puts Major Meatpacking Deal Between Marfrig and Minerva on Hold
May 19, 2024 by
CPI
Alaska Airlines Seeks Dismissal of Consumer Lawsuit Over $1.9 Billion Hawaiian Airlines Buy
May 19, 2024 by
CPI
Idaho Attorney General Orders Split of Kootenai Health and Syringa Hospital
May 19, 2024 by
CPI
Court Rejects T-Mobile’s Appeal Bid in Antitrust Case Over Sprint Merger
May 19, 2024 by
CPI
Google Requests Judge, Not Jury, to Decide on Antitrust Case
May 19, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Ecosystems
May 9, 2024 by
CPI
Mapping Antitrust onto Digital Ecosystems
May 9, 2024 by
CPI
Ecosystems and Competition Law: A Law and Political Economy Approach
May 9, 2024 by
CPI
Ecosystem Theories of Harm: What is Beyond the Buzzword?
May 9, 2024 by
CPI
Open Ecosystems: Benefits, Challenges, and Implications for Antitrust
May 9, 2024 by
CPI